Department of Pathology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Yael Raz
Department of Pathology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Obstetrics and Gynecology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Lea Monteran
Department of Pathology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Ye'ela Scharff
Department of Pathology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Oshrat Levi-Galibov
Department of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel
Or Megides
Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Hila Shacham
Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Noam Cohen
Department of Pathology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Dana Silverbush
Blavatnik School of Computer Sciences, Faculty of Exact Sciences, Tel Aviv University, Tel Aviv, Israel
Camilla Avivi
Department of Pathology, Sheba Medical Center, Tel Hashomer, affiliated with Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Roded Sharan
Blavatnik School of Computer Sciences, Faculty of Exact Sciences, Tel Aviv University, Tel Aviv, Israel
Asaf Madi
Department of Pathology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Ruth Scherz-Shouval
Department of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel
Iris Barshack
Department of Pathology, Sheba Medical Center, Tel Hashomer, affiliated with Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Ilan Tsarfaty
Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Mortality from breast cancer is almost exclusively a result of tumor metastasis, and lungs are one of the main metastatic sites. Cancer-associated fibroblasts are prominent players in the microenvironment of breast cancer. However, their role in the metastatic niche is largely unknown. In this study, we profiled the transcriptional co-evolution of lung fibroblasts isolated from transgenic mice at defined stage-specific time points of metastases formation. Employing multiple knowledge-based platforms of data analysis provided powerful insights on functional and temporal regulation of the transcriptome of fibroblasts. We demonstrate that fibroblasts in lung metastases are transcriptionally dynamic and plastic, and reveal stage-specific gene signatures that imply functional tasks, including extracellular matrix remodeling, stress response, and shaping the inflammatory microenvironment. Furthermore, we identified Myc as a central regulator of fibroblast rewiring and found that stromal upregulation of Myc transcriptional networks is associated with disease progression in human breast cancer.